Julie So-Young Kim

Chief Executive Officer, Takeda Pharmaceutical Company.

Companies

Takeda Pharmaceutical CompanyBoard member Jul 6, 2026 to now¹
Takeda Pharmaceutical CompanyPresident Jul 6, 2026 to now¹
Takeda Pharmaceutical CompanyChief executive officer Mar 18, 2026 to now²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Takeda Pharmaceutical Company TAK391,489 shares³$7.7M at $19.64Aug 10, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

Aug 10, 2026Sold 89,090 shares at $17.10 of Takeda Pharmaceutical Company³
Jul 1, 2026Granted 22,800 shares of Takeda Pharmaceutical Company⁴
Jul 1, 2026Granted 50,434 shares of Takeda Pharmaceutical Company⁴
Apr 27, 2026Granted 105,416 shares of Takeda Pharmaceutical Company⁵

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARTakeda Pharmaceutical Company, Board member
2
SEC EDGARTakeda Pharmaceutical Company, Chief executive officer
3
SEC EDGARTakeda Pharmaceutical Company shares after the filing of Aug 10, 2026
4
SEC EDGARForm 4 filed Jul 6, 2026
5
SEC EDGARForm 4 filed Apr 28, 2026